HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione.

Abstract
The aim of the present experiments was to examine anticonvulsant activity of new pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione derivatives in animal models of epilepsy. In addition, the possible collateral antinociceptive activity was assessed. Anticonvulsant activity was investigated in the electroconvulsive threshold (MEST) test and the pilocarpine-induced seizure models in mice. Antinociceptive activity was examined in the hot plate and the formalin tests in mice. Considering the drug safety evaluation, the Vibrio harveyi test was used to estimate anti/mutagenic activity. To determine the plausible mechanism of anticonvulsant action, for two chosen compounds (12 and 23), in vitro binding assays were carried out. All of the tested compounds revealed significant anticonvulsant activity in the MEST test. Compounds 12 and 23 displayed anticonvulsant effect also in pilocarpine-induced seizures. Four of the tested compounds (12, 13, 15, and 24) revealed analgesic activity in the hot plate test as well as in the first phase of the formalin test, and all of them were active in the second phase of the formalin test. The possible mechanism of action of compounds 12 and 23 is the influence on the neuronal voltage-sensitive sodium and L-type calcium channels. The obtained results indicate that in the group of pyrrolidine-2,5-diones, new anticonvulsants with collateral analgesic properties can be found.
AuthorsAnna Rapacz, Sabina Rybka, Jolanta Obniska, Kinga Sałat, Beata Powroźnik, Elżbieta Pękala, Barbara Filipek
JournalNaunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 389 Issue 3 Pg. 339-48 (Mar 2016) ISSN: 1432-1912 [Electronic] Germany
PMID26650502 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics
  • Anticonvulsants
  • Calcium Channels, L-Type
  • Mannich Bases
  • Sodium Channels
  • Succinimides
  • Pilocarpine
  • Formaldehyde
Topics
  • Analgesics (pharmacology, therapeutic use)
  • Animals
  • Anticonvulsants (pharmacology, therapeutic use)
  • Calcium Channels, L-Type (metabolism)
  • Formaldehyde
  • Hot Temperature
  • Male
  • Mannich Bases (pharmacology, therapeutic use)
  • Mice
  • Motor Activity (drug effects)
  • Mutagenicity Tests
  • Pain (drug therapy, etiology)
  • Pilocarpine
  • Seizures (chemically induced, drug therapy)
  • Sodium Channels (metabolism)
  • Succinimides (pharmacology, therapeutic use)
  • Vibrio (drug effects, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: